Annual Book Value
$114.29 M
+$102.21 M+846.08%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual book value is $114.29 million, with the most recent change of +$102.21 million (+846.08%) on March 31, 2024.
- During the last 3 years, VTGN annual book value has risen by +$22.31 million (+24.26%).
- VTGN annual book value is now at all-time high.
Performance
VTGN Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$92.97 M
-$11.83 M-11.29%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly book value is $92.97 million, with the most recent change of -$11.83 million (-11.29%) on September 30, 2024.
- Over the past year, VTGN quarterly book value has stayed the same.
- VTGN quarterly book value is now -24.59% below its all-time high of $123.28 million, reached on December 31, 2023.
Performance
VTGN Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
VTGN Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +846.1% | 0.0% |
| 3 y3 years | +24.3% | 0.0% |
| 5 y5 years | +1516.2% | 0.0% |
VTGN Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +846.1% | -24.6% | +1257.5% |
| 5 y | 5-year | at high | +2093.3% | -24.6% | +1624.5% |
| alltime | all time | at high | +656.3% | -24.6% | +552.6% |
VistaGen Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $92.97 M(-11.3%) |
| Jun 2024 | - | $104.80 M(-8.3%) |
| Mar 2024 | $114.29 M(+846.1%) | $114.29 M(-7.3%) |
| Dec 2023 | - | $123.28 M(+245.9%) |
| Sep 2023 | - | $35.65 M(+420.4%) |
| Jun 2023 | - | $6.85 M(-43.3%) |
| Mar 2023 | $12.08 M(-81.3%) | $12.08 M(-41.6%) |
| Dec 2022 | - | $20.67 M(-30.2%) |
| Sep 2022 | - | $29.61 M(-35.7%) |
| Jun 2022 | - | $46.05 M(-28.8%) |
| Mar 2022 | $64.72 M(-29.6%) | $64.72 M(-19.1%) |
| Dec 2021 | - | $79.98 M(-0.8%) |
| Sep 2021 | - | $80.66 M(-5.8%) |
| Jun 2021 | - | $85.61 M(-6.9%) |
| Mar 2021 | $91.97 M(-1704.2%) | $91.97 M(-2.0%) |
| Dec 2020 | - | $93.80 M(+2123.6%) |
| Sep 2020 | - | $4.22 M(-175.1%) |
| Jun 2020 | - | -$5.62 M(-2.1%) |
| Mar 2020 | -$5.73 M(-181.1%) | -$5.73 M(-6.0%) |
| Dec 2019 | - | -$6.10 M(+67.8%) |
| Sep 2019 | - | -$3.63 M(-324.1%) |
| Jun 2019 | - | $1.62 M(-77.1%) |
| Mar 2019 | $7.07 M(+2.3%) | $7.07 M(+318.7%) |
| Dec 2018 | - | $1.69 M(-57.6%) |
| Sep 2018 | - | $3.99 M(+23.9%) |
| Jun 2018 | - | $3.22 M(-53.5%) |
| Mar 2018 | $6.91 M(+1029.9%) | $6.91 M(-32.6%) |
| Dec 2017 | - | $10.26 M(-712.2%) |
| Sep 2017 | - | -$1.68 M(+174.3%) |
| Jun 2017 | - | -$610.80 K(-199.8%) |
| Mar 2017 | $611.80 K | $611.80 K(-76.3%) |
| Dec 2016 | - | $2.58 M(-36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $4.08 M(-33.7%) |
| Jun 2016 | - | $6.16 M(-306.4%) |
| Mar 2016 | -$2.98 M(-85.5%) | -$2.98 M(+86.2%) |
| Dec 2015 | - | -$1.60 M(+20.6%) |
| Sep 2015 | - | -$1.33 M(-53.7%) |
| Jun 2015 | - | -$2.87 M(-86.0%) |
| Mar 2015 | -$20.54 M(+60.5%) | -$20.54 M(+15.5%) |
| Dec 2014 | - | -$17.78 M(+2.4%) |
| Sep 2014 | - | -$17.37 M(+12.9%) |
| Jun 2014 | - | -$15.39 M(+20.2%) |
| Mar 2014 | -$12.80 M(+1.9%) | -$12.80 M(+9.7%) |
| Dec 2013 | - | -$11.67 M(-8.5%) |
| Sep 2013 | - | -$12.75 M(+6.7%) |
| Jun 2013 | - | -$11.95 M(-4.8%) |
| Mar 2013 | -$12.56 M(+120.1%) | -$12.56 M(+19.3%) |
| Dec 2012 | - | -$10.52 M(+62.9%) |
| Sep 2012 | - | -$6.46 M(+2.8%) |
| Jun 2012 | - | -$6.28 M(+10.1%) |
| Mar 2012 | -$5.71 M(>+9900.0%) | -$5.71 M(+19.8%) |
| Dec 2011 | - | -$4.76 M(-45.4%) |
| Sep 2011 | - | -$8.72 M(+23.5%) |
| Jun 2011 | - | -$7.07 M(>+9900.0%) |
| Mar 2011 | - | -$300.00(-70.0%) |
| Dec 2010 | -$1000.00(+900.0%) | -$1000.00(+42.9%) |
| Sep 2010 | - | -$700.00(-170.0%) |
| Jun 2010 | - | $1000.00(+900.0%) |
| Mar 2010 | - | $100.00(-200.0%) |
| Dec 2009 | -$100.00(-100.5%) | -$100.00(-107.7%) |
| Sep 2009 | - | $1300.00(+18.2%) |
| Jun 2009 | - | $1100.00(-94.6%) |
| Dec 2008 | $20.40 K | $20.40 K(-682.9%) |
| Jun 2008 | - | -$3500.00(+45.8%) |
| Mar 2008 | - | -$2400.00 |
FAQ
- What is VistaGen Therapeutics annual book value?
- What is the all time high annual book value for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual book value year-on-year change?
- What is VistaGen Therapeutics quarterly book value?
- What is the all time high quarterly book value for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly book value year-on-year change?
What is VistaGen Therapeutics annual book value?
The current annual book value of VTGN is $114.29 M
What is the all time high annual book value for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual book value is $114.29 M
What is VistaGen Therapeutics annual book value year-on-year change?
Over the past year, VTGN annual book value has changed by +$102.21 M (+846.08%)
What is VistaGen Therapeutics quarterly book value?
The current quarterly book value of VTGN is $92.97 M
What is the all time high quarterly book value for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly book value is $123.28 M
What is VistaGen Therapeutics quarterly book value year-on-year change?
Over the past year, VTGN quarterly book value has changed by $0.00 (0.00%)